Loading...
Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor
Rhabdoid tumor (RT) is a pediatric cancer characterized by the inactivation of SMARCB1, a subunit of the SWI/SNF chromatin remodeling complex. Although this deletion is the known oncogenic driver, there are limited effective therapeutic options for these patients. Here we use unbiased screening of c...
Saved in:
| Published in: | EMBO Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7863405/ https://ncbi.nlm.nih.gov/pubmed/33332735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202012640 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|